Huakang Biomedical Holdings Co (HKSE:08622) Dividend Payout Ratio : 0.00 (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Huakang Biomedical Holdings Co Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Huakang Biomedical Holdings Co's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.00.

The historical rank and industry rank for Huakang Biomedical Holdings Co's Dividend Payout Ratio or its related term are showing as below:

HKSE:08622's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.37
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-12-12), the Dividend Yield % of Huakang Biomedical Holdings Co is 0.00%.

Huakang Biomedical Holdings Co's Dividends per Share for the months ended in Jun. 2024 was HK$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Huakang Biomedical Holdings Co Dividend Payout Ratio Historical Data

The historical data trend for Huakang Biomedical Holdings Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huakang Biomedical Holdings Co Dividend Payout Ratio Chart

Huakang Biomedical Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

Huakang Biomedical Holdings Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Huakang Biomedical Holdings Co's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Huakang Biomedical Holdings Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huakang Biomedical Holdings Co's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huakang Biomedical Holdings Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Huakang Biomedical Holdings Co's Dividend Payout Ratio falls into.

Huakang Biomedical Holdings Co Dividend Payout Ratio Calculation

Huakang Biomedical Holdings Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	-0.015
	=	N/A

Huakang Biomedical Holdings Co's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2024 )	/	EPS without NRI (Q: Jun. 2024 )
	=	0	/	0
	=	N/A

Huakang Biomedical Holdings Co (HKSE:08622) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Huakang Biomedical Holdings Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Huakang Biomedical Holdings Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Huakang Biomedical Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huakang Biomedical Holdings Co Ltd (HKSE:08622) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.16 Yinkui Road, 1-3 floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN

Website

http://www.szhuakang.com

Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.

Executives

Arena Investment Management (singapore) Pte Ltd	2102 Investment manager
Arena Investors, Lp	2102 Investment manager
Arena Sg Spv I, Llc	2201 Interest of corporation controlled by you
Tgga, Llc	2106 Person having a security interest in shares
Lau Lai Yee	2201 Interest of corporation controlled by you
Kokusai Resources Company Limited	2101 Beneficial owner
Zhang Shuguang	2101 Beneficial owner
Crystal Grant Limited	2101 Beneficial owner
Chang Yim Yang	2401 A concert party to an agreement to buy shares
Ever Charming Inc.	2101 Beneficial owner
Wealthy Pride Investment Limited	2101 Beneficial owner

Huakang Biomedical Holdings Co Headlines

No Headlines